| Segment Reporting [Table Text Block] |
| |
|
Three Months Ended June 30, 2026 |
|
|
Six months ended June 30, 2026 |
|
| |
|
Chemical |
|
|
Biofuel |
|
|
Total |
|
|
Chemical |
|
|
Biofuel |
|
|
Total |
|
| Revenue |
|
$ |
25,849 |
|
|
$ |
52,877 |
|
|
$ |
78,726 |
|
|
$ |
45,481 |
|
|
$ |
65,197 |
|
|
$ |
110,678 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of goods sold |
|
|
20,593 |
|
|
|
42,029 |
|
|
|
62,623 |
|
|
|
42,387 |
|
|
|
67,247 |
|
|
|
109,635 |
|
| Distribution |
|
|
319 |
|
|
|
761 |
|
|
|
1,080 |
|
|
|
676 |
|
|
|
1,202 |
|
|
|
1,878 |
|
| Segment gross profit (loss) |
|
$ |
4,937 |
|
|
$ |
10,087 |
|
|
$ |
15,023 |
|
|
$ |
2,418 |
|
|
$ |
(3,252 |
) |
|
$ |
(835 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reconciliation of Segment gross profit (loss) to Net income (loss) before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Selling, general, and administrative expenses |
|
|
|
|
|
|
|
|
|
$ |
3,080 |
|
|
|
|
|
|
|
|
|
|
$ |
7,225 |
|
| Research and development expenses |
|
|
|
|
|
|
|
|
|
|
692 |
|
|
|
|
|
|
|
|
|
|
|
1,532 |
|
| Other income, net |
|
|
|
|
|
|
|
|
|
|
(188 |
) |
|
|
|
|
|
|
|
|
|
|
(457 |
) |
| Net income (loss) before income taxes |
|
|
|
|
|
|
|
|
|
$ |
11,439 |
|
|
|
|
|
|
|
|
|
|
$ |
(9,135 |
) |
| |
|
Three Months Ended June 30, 2025 (As Adjusted (Note 1)) |
|
|
Six months ended June 30, 2025 (As Adjusted (Note 1)) |
|
| |
|
Chemical |
|
|
Biofuel |
|
|
Total |
|
|
Chemical |
|
|
Biofuel |
|
|
Total |
|
| Revenue |
|
$ |
16,619 |
|
|
$ |
19,054 |
|
|
$ |
35,673 |
|
|
$ |
25,984 |
|
|
$ |
27,227 |
|
|
$ |
53,211 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of goods sold |
|
|
15,211 |
|
|
|
32,177 |
|
|
|
47,388 |
|
|
|
30,351 |
|
|
|
49,224 |
|
|
|
79,575 |
|
| Distribution |
|
|
294 |
|
|
|
384 |
|
|
|
678 |
|
|
|
534 |
|
|
|
683 |
|
|
|
1,217 |
|
| Segment gross profit (loss) |
|
$ |
1,114 |
|
|
$ |
(13,507 |
) |
|
$ |
(12,393 |
) |
|
$ |
(4,901 |
) |
|
$ |
(22,680 |
) |
|
$ |
(27,581 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reconciliation of Segment gross profit (loss) to Net loss before income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Selling, general, and administrative expenses |
|
|
|
|
|
|
|
|
|
$ |
2,228 |
|
|
|
|
|
|
|
|
|
|
$ |
5,112 |
|
| Research and development expenses |
|
|
|
|
|
|
|
|
|
|
933 |
|
|
|
|
|
|
|
|
|
|
|
2,324 |
|
| Other income, net |
|
|
|
|
|
|
|
|
|
|
(1,547 |
) |
|
|
|
|
|
|
|
|
|
|
(2,748 |
) |
| Net loss before income taxes |
|
|
|
|
|
|
|
|
|
$ |
(14,007 |
) |
|
|
|
|
|
|
|
|
|
$ |
(32,269 |
) |
|